This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quan, M. L. Articles by McKinnon, J. G. Search for Related Content PubMed PubMed Citation Articles by Quan, M. L. Articles by McKinnon, J. G. Related Collections Metastases

Biology of Lymphatic Metastases in Breast Cancer: Lessons Learned From Sentinel Node Biopsy

From the Division of General Surgery (MLQ, WJT, JGM), University of Calgary, Calgary, Alberta, Canada; and the Division of General Surgery (DM), University of Toronto, Toronto, Ontario, Canada.

Correspondence: Address correspondence and reprint requests to: J. Gregory McKinnon, MD, Foothills Medical Centre, 1403 29th St., N.W., Calgary, Alberta, Canada, T2N 2T9; Fax: 403-283-1651; E-mail: mckinnon{at}ucalgary.ca

Background: The evolution of sentinel node biopsy has placed new emphasis on the biology of lymphatic metastases in breast cancer. If radiocolloid mimics the migration of tumor cells, the nodes with the most uptake should also be the most likely to harbor metastatic cells. We attempted to correlate the frequency of metastatic disease to the greatest gamma uptake and to clarify the physiology of breast lymphatic drainage.

Methods: Data were collected from 152 patients undergoing sentinel node biopsy from January 1997 to June 1999. Localization was by injection of unfiltered ^99mTc-labeled sulfur colloid. Sentinel nodes were identified with an intraoperative gamma counter and the 10% rule. A completion level I/II axillary dissection was performed in all patients.

Results: Fifty-four of 152 patients were positive for metastatic disease. There were no false-negative sentinel nodes. In 46 (85%) of 54 cases, the node with the highest uptake was positive for metastatic disease. In the remaining eight (15%) cases, another node with a lower gamma count was positive.

Conclusions: The sentinel node with the highest uptake is not the one that contains metastatic disease in 15% of cases. This may reflect variations in lymphatic channels or technical variations in colloid properties and injection technique.

Key Words: Breast cancer • Lymphatic metastases • Sentinel node biopsy • Radiocolloid localization

This article has been cited by other articles:

				J.-M. Classe, M. Fiche, C. Rousseau, C. Sagan, F. Dravet, R. Pioud, A. Lisbona, L. Ferrer, L. Campion, I. Resche, et al. Prospective Comparison of 3 {gamma}-Probes for Sentinel Lymph Node Detection in 200 Breast Cancer Patients J. Nucl. Med., March 1, 2005; 46(3): 395 - 399. [Abstract] [Full Text] [PDF]

				D. R. McCready, W. S. Yong, A. K. T. Ng, N. Miller, S. Done, and B. Youngson Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates J Natl Cancer Inst, June 2, 2004; 96(11): 873 - 875. [Abstract] [Full Text] [PDF]